Profound Medical Q1 2024 GAAP EPS $(0.26) Beats $(0.30) Estimate, Sales $1.910M Miss $2.521M Estimate
Profound Medical Q1 2024 GAAP EPS $(0.26) Beats $(0.30) Estimate, Sales $1.910M Miss $2.521M Estimate
Profound Medical 2024年第一季度GAAP每股收益美元（0.26美元）超过预期（0.30美元），销售额19.1万美元低于2521万美元的预期
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) by 13.33 percent. This is a 18.75 percent increase over losses of $(0.32) per share from the same period last year. The company reported quarterly sales of $1.910 million which missed the analyst consensus estimate of $2.521 million by 24.24 percent. This is a 2.69 percent increase over sales of $1.860 million the same period last year.
Profound Medical（纳斯达克股票代码：PROF）公布的季度亏损为每股0.26美元，比分析师普遍预期的0.30美元（0.30美元）高出13.33％。这比去年同期每股亏损0.32美元（0.32美元）增长了18.75％。该公司公布的季度销售额为19.1亿美元，比分析师普遍预期的2521万美元低24.24％。这比去年同期的18.6亿美元销售额增长了2.69％。